International Medical Research Frontier

Objective To observe the clinical efficacy of bromhexin combined with cefuroxime sodium in the treatment of pediatric pneumonia. Methods This study was conducted from January 2021 to January 2022. The subjects were 80 children with pneumonia treated in our hospital during the above period. The above patients were randomly divided into two groups. One group was the routine group, receiving vitamin+cefuroxime sodium treat- ment, and the other group was the combined group, receiving bromohexidine combined with cefuroxime sodium treatment. The effects of the two groups were compared after treatment. Results in the comparison of the effective rate of the two groups, the effective rate of the combined group was 97.5%, while the effective rate of the con- ventional group was 77.5%, which was significantly lower than that of the combined group (P<0.05); In the compa- rison of the disappearance time of clinical symptoms (cough, fever, lung moist rale, wheezing disappearance), the disappearance time of all symptoms in the combined group was shorter than that in the conventional group after treatment, P<0.05; The incidence of adverse reactions in the combined group was significantly lower than that in the conventional group (P<0.05). Conclusion in the treatment of children with pneumonia, bromohexidine com- bined with cefuroxime sodium will achieve a relatively ideal therapeutic effect, which is worth using.

Bromohexidine; Cefuroxime sodium; Combination therapy; Pediatric pneumonia; Clinical efficacy